NCT06196541

Brief Summary

In the literature, it is still unclear whether individuals with chronic venous insufficiency are affected by edema, pain, respiratory muscle strength, respiratory functions, functional capacity, lower extremity strength and quality of life compared to asymptomatic healthy individuals and if there is a deterioration in these parameters, its level is still unclear. For this reason, in this study it was aimed to investigate edema, pain, respiratory muscle strength, respiratory function, functional capacity, lower extremity strength and quality of life in individuals with chronic venous insufficiency and asymptomatic healthy individuals and to compare these parameters between the two groups.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Dec 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Dec 2023Dec 2026

First Submitted

Initial submission to the registry

December 24, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

December 27, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 9, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2026

Expected
Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

2 years

First QC Date

December 24, 2023

Last Update Submit

May 16, 2025

Conditions

Keywords

edemapainvenous insufficiencyquality of liferespiratory function testsmaximal respiratory pressuresexercise capacity

Outcome Measures

Primary Outcomes (2)

  • Maximal inspiratory pressure (MIP)

    The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    through study completion, an average of 1 year

  • Maximal expiratory pressure (MEP)

    The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    through study completion, an average of 1 year

Secondary Outcomes (10)

  • Pain Intensity measured with the Numerical Rating Scale.

    through study completion, an average of 1 year

  • The distance of six-minute walk test

    through study completion, an average of 1 year

  • Lower extremity strength

    through study completion, an average of 1 year

  • Total quality of life score evaluated by Chronic Venous Disease Quality of Life Questionnaire

    through study completion, an average of 1 year

  • Forced vital capacity (FVC)

    through study completion, an average of 1 year

  • +5 more secondary outcomes

Study Arms (2)

Individuals with Chronic Venous Insufficiency

Edema, pain, respiratory functions, physical functions and quality of life will be evaluated in individuals with chronic venous insufficiency.

Asymptomatic Healthy Individuals

Edema, pain, respiratory functions, physical functions and quality of life will be evaluated in asymptomatic healthy individuals.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Volunteer adult individuals diagnosed with chronic venous insufficiency by a Cardiovascular Specialist and healthy volunteer adult individuals without a diagnosis of chronic venous insufficiency will be included in this study.

You may qualify if:

  • Being diagnosed with chronic venous insufficiency
  • Being in one of the C1, C2, C3, C4, C5 stages according to the 'Clinical, Etiologic, Anatomic, Pathophysiologic' (CEAP) scale
  • Volunteering to participate in the study
  • years of age or older

You may not qualify if:

  • Presence of arterial disease,
  • The presence of advanced cardiorespiratory diseases,
  • Orthopaedic and neurological disorders affecting walking,
  • Presence of acute ulcers (\< 3 months) and diabetic ulcers,
  • Being pregnant.
  • History of deep vein thrombosis,
  • Presence of active infection
  • years of age and older
  • Volunteering to participate in the study
  • Individuals who can understand and answer questionnaires and measurements
  • Individuals with any physical or mental disability
  • Individuals with any acute or chronic infection and/or health problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Democracy University

Izmir, 35140, Turkey (Türkiye)

Location

Related Publications (3)

  • Kunimoto B, Cooling M, Gulliver W, Houghton P, Orsted H, Sibbald RG. Best practices for the prevention and treatment of venous leg ulcers. Ostomy Wound Manage. 2001 Feb;47(2):34-46, 48-50.

    PMID: 11235498BACKGROUND
  • de Moura RM, Gomes Hde A, da Silva SL, Britto RR, Dias RC. Analysis of the physical and functional parameters of older adults with chronic venous disease. Arch Gerontol Geriatr. 2012 Nov-Dec;55(3):696-701. doi: 10.1016/j.archger.2012.05.005. Epub 2012 Jun 7.

    PMID: 22682424BACKGROUND
  • Aydin G, Yeldan I, Akgul A, Ipek G. Effects of inspiratory muscle training versus calf muscle training on quality of life, pain, venous function and activity in patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1137-1146. doi: 10.1016/j.jvsv.2022.04.012. Epub 2022 Jun 14.

    PMID: 35710091BACKGROUND

MeSH Terms

Conditions

EdemaPainVenous Insufficiency

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsNeurologic ManifestationsVascular DiseasesCardiovascular Diseases

Study Officials

  • GÜLŞAH BARĞI, Assoc. Dr.

    Izmir Democracy University

    STUDY DIRECTOR
  • ÖZLEM ÖZLEM ÇİNAR ÖZDEMİR, Assoc. Dr.

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • CEMRE GÖRÜNMEZOĞLU, MSc

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • SADIK KIVANÇ METİN, Prof. Dr.

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR
  • ECEM ÖZDEMİR

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR
  • EMEK NAZIM EKER

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR
  • ANIL GİRGİN

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof.

Study Record Dates

First Submitted

December 24, 2023

First Posted

January 9, 2024

Study Start

December 27, 2023

Primary Completion

December 27, 2025

Study Completion (Estimated)

December 27, 2026

Last Updated

May 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations